Objectıve: Rheumatic mitral stenosis (MS) is still a common disease in developing countries with high morbidity and mortality rates. The aim of the study was to evaluate left atrial mechanical functions in MS before and after percutaneous mitral balloon valvuloplasty (PMBV) and following in short and mid term. Methods: the study included 49 patients with critical mitral stenosis who have normal sinus rhythm (male/female:14 to 35; mean age: 42AE11). Left atrial mechanical functions were evaluated before, after, 3 months after and 1 year after PMBV, including Left atrial passive emptying volume (LAPEV), LA active emptying volume (LAAEV), LA total emptying volume (LATEV), LA passive emptying fraction (LAPEF), LA active emptying fraction (LAAEF), LA total emptying fraction (LATEF) and conduit volume (figure1). Results: The transthoracic echocardiography parameters of the mitral stenosis patients before, after, 3 months after and 1 year after percutaneous mitral balloon valvuloplasty were as follows: a) Mitral valve area: 1.1 cm 2 (0.9-1.6); 2.2 cm 2 (1. Conclusıon: our finding showed that improvement of left atrial mechanical functions after successful treatment of MS with PMBV and this improvement continues for one year.
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(28-57) (p<0.001); c) Left atrial passive emptying volume (LAPEV): 13 ml/m 2 (9-27); 11 ml/m 2 (8-19) (p<0.001); 10 ml/m 2 (7-19) (p<0.001); 10 ml/m 2 (6-18) (p<0.001);d) LA active emptying volume (LAAEV): 12 ml/m 2 (8-23); 10 ml/m 2 (6-21) (p<0.001); 9 ml/m 2 (5-17) (p<0.001); 9 ml/m 2 (4-16) (NS) e) LA total emptying volume (LATEV): 26 ml/m 2 (19-50); 21 ml/m 2 (16-40) (p<0.001); 20 ml/m 2 (15-36) (p<0.001); 19 ml/m 2 (15-34) p<0.001);f) Conduit volume: 30 ml/m 2 (22-44); 33 ml/ m 2 (26-46) p<0.001); 34 ml/m 2 (30-42) p<0.001); 36 ml/m 2 (31-42) p<0.001), respectively. However LA passive emptying fraction (LAPEF), LA active emptying fraction (LAAEF) and LA total emptying fraction (LATEF) were not altered after PMBV (table1).
Conclusıon: our finding showed that improvement of left atrial mechanical functions after successful treatment of MS with PMBV and this improvement continues for one year.
PP-215
Relation between Glycosylated Hemoglobin (Hemoglobin A1c) Background: Type 2 diabetes mellitus (DM) is a major risk factor for cardiovascular diseases and responsible for increased cardiovascular mortality. Chronic hyperglycemia is related with accelerated atherosclerosis. In this study, we tried to demonstrate the relation between glycosylated hemoglobin (HbA1c) level which is a marker of long standing hyperglycemia and aortic stiffness which is a marker of cardiovascular disease. Method and Results: 100 patients with newly diagnosis type 2 diabetes mellitus were included this study. The patients divided into 3 groups according to HbA1c level (Group 1 HbA1c 6, group 2 HbA1c 6-7 and group 3 HbA1c >7). Statistically significant difference was found between groups according to blood glucose level, DM duration and oral antidiabetic and insulin therapy (Table 1) . Aortic systolicdiastolic diameter, aortic strain and aortic distensibility were similar between group 1 and group 2 whereas in group 3, aortic systolic-diastolic diameter, aortic strain and aortic distensibility were significantly lower than group 1 and group 2 (p<0.001) ( Table 2 ). Significant correlation was found between aortic distensibility and HbA1c level (r¼0,283; p:0,004) ( Figure 1 ). Moreover, aortic distensibility was Comparison of before and after PMBV LA mechanic functional parameters measured by Transthoracic Echocardiography also correlated with DM duration (r¼-0,172; p: 0,05) and age (r¼-0,27; p:0,006). Significant correlation was determined between aortic strain and fasting blood glucose, HbA1c level and DM duration (respectively r¼-0,265; p:0,008, r¼0,279; p:0,005 ve r¼-0,14; p:0,03) (Table 3 and Figure 2) . Conclusıon: In this study, we showed that aortic stiffness was increased in newly diagnosis diabetes mellitus. Echocardiographically noninvasive evaluation of aortic stiffness may be helpful in estimation of cardiovascular risk in patients with diabetes mellitus.
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Introductıon: It is well known that diabetes leads to impairment of atrial fuctions. Nevertheless, impaired atrial function is an independent predictor of atrial fibrillation.
Although there are several studies demonstrating impaired atrial functions in diabetic patients, data regarding pre-diabetic (Pre-DM) patients are scarce. The aim of this study was to evaluate atrial functions including mechanical and tissue doppler parameters in pre-diabetic patients. Methods: We enrolled 80 patients diagnosed with pre-diabetes and 40 controls with normal glucose levels. Pre-diabetes was diagnosed according to American Diabetes Association (ADA-2013) guidelines. According to the ADA guidelines 27 of our patients were isolated in the impaired fasting glucose group (i-IFG) pre-dm and 53 
